ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DEST Destiny Pharma Plc

17.50
0.50 (2.94%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Destiny Pharma Plc LSE:DEST London Ordinary Share GB00BDHSP575 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 2.94% 17.50 17.00 18.00 17.50 17.50 17.50 599 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -6.5M -0.0683 -2.49 16.2M
Destiny Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker DEST. The last closing price for Destiny Pharma was 17p. Over the last year, Destiny Pharma shares have traded in a share price range of 13.50p to 83.00p.

Destiny Pharma currently has 95,271,863 shares in issue. The market capitalisation of Destiny Pharma is £16.20 million. Destiny Pharma has a price to earnings ratio (PE ratio) of -2.49.

Destiny Pharma Share Discussion Threads

Showing 376 to 397 of 2900 messages
Chat Pages: Latest  20  19  18  17  16  15  14  13  12  11  10  9  Older
DateSubjectAuthorDiscuss
21/1/2021
20:28
Anyone tune in to the presentation?
mikeh30
21/1/2021
14:40
that video now on ggp share board , a good example for other shares
bunz3
20/1/2021
13:15
Biden and the next chapter for global stock markets (podcast with discussion on Destiny Pharma).
sev22
20/1/2021
12:21
I am in no way a chartist but is that a cup and handle formation ?
okidokicoki
19/1/2021
18:37
Would like to see a partnership between DP and Oxford as the latter have the brand and the capital backing and together I think they could be a great partnership....
supracat
19/1/2021
17:58
I see the Oxford Institute AMR news as being very positive for DEST. This will clearly raise awareness of the demand for AMR drugs and the opportunity therein. Fact is DEST must be 5 - 10 years ahead of the Oxford Inst, bearing in mind they are just setting up and DEST at end of P2B.

Good to see step up in PR with these 2 events and more. I presume timed to closely coincide with the P2B results.

kipper1960
19/1/2021
16:34
Looks like there are two opportunities to listen to te investment case in the next couple of weeks

Destiny are also presenting at the Proactive one2one investors forum this Thursday (21st January)

Click here to register

timbo003
19/1/2021
13:21
Shares Investor Evening - Webinar.
sev22
19/1/2021
11:21
Also added
malcolmmm
19/1/2021
10:13
Lengthy segment too for sky news. Huge huge focus on AMR
mikeh30
19/1/2021
10:11
Great news this as brings the sector into the radar and DP should benefit off the back of this as being at the forefront.
supracat
19/1/2021
09:34
Added at 112
prince7652
19/1/2021
09:34
Wh1spa Very good article if only there was something in trials that could solve the problem :-)
okidokicoki
19/1/2021
09:23
It's doubled in a short time. Profits taken yesterday now the inexperienced booking losses. Yawn. Wake me up at £3
mikeh30
19/1/2021
09:20
MMs trying to shake out some sellers past couple of days with these share price movements and spreads.
supracat
18/1/2021
11:51
Just been down the back of the sofa and bought a few more:-)
okidokicoki
18/1/2021
11:24
It's not just that it's preventative that I like (an ounce of prevention) it's also that the XF-73 platform will continue to produce further gels and sprays and that each of these will be used by doctors and surgeons as consumables.

If the trials are successful and we get the right commercial partner (probably already well underway) the goal is to get into the lucrative US market and for our preventative medicines to be used routinely to prevent MRSA and COVID.

Looks very positive here for the next few years.

gb904150
18/1/2021
11:07
VoluMe is stil quite low despite the share price rises.
supracat
18/1/2021
10:34
Must be starting to get on people's radar with the rises we have had in the last few weeks, its almost doubled in price in the last few weeks . Its a beautiful thing :-)
okidokicoki
18/1/2021
08:53
I totally agree. This could be very big.
idriveajag
16/1/2021
07:53
Ty Carlisle. Hope you are also holding a good number too.
supracat
15/1/2021
15:59
Another good day and another decent uplift off the back of this momentum. Next challenge line of resistance is still around 190p so will be interesting to see what happens over the coming days and weeks. I firmly believe the recent CBO role is ahead of positive results in Q1 from the Xf73 trials. Assuming good trial data coming through I'd like to see a clear plan and who DP will partner with to get through Phase 3, and critically what cash up front has been agreed.
supracat
Chat Pages: Latest  20  19  18  17  16  15  14  13  12  11  10  9  Older

Your Recent History

Delayed Upgrade Clock